» Articles » PMID: 34522797

The Effect of CHRNA3 Rs1051730 C>T and ABCB1 Rs3842 A>G Polymorphisms on Non-small Cell Lung Cancer and Nicotine Dependence in Iranian Population

Overview
Journal Heliyon
Specialty Social Sciences
Date 2021 Sep 15
PMID 34522797
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Lung cancer is still the leading cause of cancer mortality in all over the world. Nicotine and its derivatives are the most well-known carcinogens that participate in both etiology and progression of lung cancer. The objective of the current study was to investigate whether single nucleotide polymorphisms (SNPs) rs1051730C > T in CHRNA3 and rs3842A > G in ABCB1, two genes contributing in the mechanism of disposition and metabolism of nicotine and its derivatives, could modify the risk of developing lung cancer, as well as nicotine dependence in Iranian.

Main Methods: The genotyping analysis for these two SNPs was conducted in a case-control study of 108 lung cancer cases and 120 healthy controls using ARMS-PCR and Tetra-primer ARMS-PCR techniques. The correlation between studied SNPs and lung cancer was assessed by the regression analysis.

Key Findings: We observed a significant association between lung cancer and rs1051730C > T by using four genetic models: allele (OR:1.83; 95% CI:1.24-2.6; p = 0.002), dominant (OR: 2.19; 95% CI:1.27-3.78; p = 0.005), recessive (OR: 2.25; 95% CI: 1.02-4.95; p = 0.043) and additive (TT vs CC: OR:3.25; 95% CI:1.38-7.60; p = 0.007, CT vs CC: OR:1.96; 95% CI:1.10-3.48; p = 0.021). Furthermore, a significant association between this variant and nicotine dependence (OR: 2.27; 95% CI: 1.52-3.39; p = 0.00005) was reported. However, no association was found for rs3842A > G.

Significance: The results suggested that the CHRNA3 rs1051730C > T via a smoking-dependent manner could modify susceptibility to lung cancer among Iranian population.

Citing Articles

Genetic analysis of suicide: a sample study in Tuscany (Central Italy).

Focardi M, Gualco B, Pinchi V, Gian-Aristide N, Rensi R, Pelo E Forensic Sci Res. 2023; 7(4):790-797.

PMID: 36817247 PMC: 9930793. DOI: 10.1080/20961790.2020.1835156.

References
1.
Hodges L, Markova S, Chinn L, Gow J, Kroetz D, Klein T . Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein). Pharmacogenet Genomics. 2010; 21(3):152-61. PMC: 3098758. DOI: 10.1097/FPC.0b013e3283385a1c. View

2.
Han Z, Jiang Q, Zhang T, Wu X, Ma R, Wang J . Analyzing large-scale samples confirms the association between the rs1051730 polymorphism and lung cancer susceptibility. Sci Rep. 2015; 5:15642. PMC: 4623668. DOI: 10.1038/srep15642. View

3.
Scheffer G, Pijnenborg A, Smit E, Muller M, Postma D, Timens W . Multidrug resistance related molecules in human and murine lung. J Clin Pathol. 2002; 55(5):332-9. PMC: 1769658. DOI: 10.1136/jcp.55.5.332. View

4.
Shiraishi K, Kohno T, Kunitoh H, Watanabe S, Goto K, Nishiwaki Y . Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese. Carcinogenesis. 2008; 30(1):65-70. DOI: 10.1093/carcin/bgn257. View

5.
Kupiainen H, Kuokkanen M, Kontto J, Virtamo J, Salomaa V, Lindqvist A . CHRNA5/CHRNA3 Locus Associates with Increased Mortality among Smokers. COPD. 2016; 13(4):464-70. DOI: 10.3109/15412555.2015.1049260. View